We are live on ! Find out more
CRIG

Charter Research & Investment Group Portfolio holdings

AUM $165M
1-Year Est. Return 37.49%
This Fund
S&P 500
This Quarter Est. Return
+8.48%
1 Year Est. Return
+37.49%
3 Year Est. Return
+82.27%
5 Year Est. Return
+111.58%
10 Year Est. Return
–
AUM
$98.4M
AUM Growth
+$6.04M
Cap. Flow
-$783K
Cap. Flow %
-0.8%
Top 10 Hldgs %
40.03%
Holding
80
New
5
Increased
28
Reduced
20
Closed
2
Avg Time Held
15 quarters
Top 10 Avg Time Held
9.5 quarters
Top 20 Avg Time Held
10.4 quarters

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$715K
2
HON icon
Honeywell
HON
+$241K
3
DUK icon
Duke Energy
DUK
+$213K
4
CSX icon
CSX Corp
CSX
+$204K
5
BDX icon
Becton Dickinson
BDX
+$194K

Sector Composition

Rank Sector Weight
1 Communication Services 18.84%
2 Healthcare 15.16%
3 Consumer Staples 14.39%
4 Technology 14.17%
5 Financials 7.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
CSX icon
76
CSX Corp
CSX
$87.9B
$208K 0.21%
+8,640
New +$204K
2019 Q4
0 quarters
BDX icon
77
Becton Dickinson
BDX
$48.2B
$207K 0.21%
+780
New +$194K
2019 Q4
0 quarters
CELG.RT
78
Bristol-Myers Squibb Rights
CELG.RT
$263M
$39K 0.04%
+12,797
New +$5.57K
2019 Q4
0 quarters
NEU icon
79
NewMarket
NEU
$8.5B
– –
-768
Closed -$363K –
CELG
80
DELISTED
Celgene Corp
CELG
– –
-12,757
Closed -$1.27M –

Similar funds

Charter Research & Investment Group's Q4 2019 Portfolio in Review

As of Q4 2019, Charter Research & Investment Group held 80 positions worth $98.4M, up 6.5% from $92.3M the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Charter Research & Investment Group's Q4 2019 filing shows 5 new, 28 increased, 20 reduced and 2 closed positions. Its largest new stake was Honeywell: 1,473 shares worth $246K. The largest sale was Celgene Corp, an estimated $1.27M.

By sector, the portfolio is most concentrated in Communication Services at 19% of assets, up from 19% a quarter earlier, followed by Healthcare and Consumer Staples.

  • Charter Research & Investment Group's largest Q4 2019 buy was Honeywell: 1,473 shares worth $246K.
  • Charter Research & Investment Group added most to Bristol-Myers Squibb in Q4 2019, an estimated $715K increase.
  • Charter Research & Investment Group's biggest Q4 2019 reduction was GE Aerospace, cutting an estimated $431K.
  • Charter Research & Investment Group fully exited Celgene Corp in Q4 2019, selling an estimated $1.27M.
  • Charter Research & Investment Group's ten largest holdings make up 40% of its $98.4M portfolio in Q4 2019.
  • Charter Research & Investment Group opened 5 new positions and closed 2 in Q4 2019.
  • Charter Research & Investment Group's portfolio value rose 6.5% quarter-over-quarter to $98.4M.

Based on Charter Research & Investment Group's 13F filing for Q4 2019, filed 30 Jan 2020.